Update: 28.06.2022
Last week: 24 week 2022 (13.06.2022 - 19.06.2022)
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 67 482 | -51.9% | 3.3% | -2.5 | 13 815 442 | -50.3% | 3.1% | -2.2 | -15.7% |
| YTD | 5 848 400 | 48.1% | 6.0% | 1.2 | 1 156 879 606 | 76.6% | 5.7% | 1.5 | 19.1% |
| MAT | 15 168 378 | 64.3% | 6.8% | 2 | 2 792 538 406 | 94.7% | 6.3% | 2.1 | 15.7% |
| DEXALGIN | |||||||||
| WoW | 18 656 | -46.0% | 0.5% | -0.3 | 8 371 881 | -42.9% | 1.3% | -0.8 | -9.2% |
| YTD | 1 008 281 | 34.9% | 0.8% | 0.1 | 416 384 046 | 47.1% | 2.1% | 0.3 | 15.0% |
| MAT | 2 099 737 | 8.6% | 0.8% | 0 | 834 312 630 | 16.6% | 2.1% | 0.1 | 6.6% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 54 025 | -41.3% | 52.9% | -10.7 | 28 300 356 | -39.5% | 61.5% | -8.7 | -29.5% |
| YTD | 2 575 601 | 10.3% | 63.1% | -10.3 | 1 297 406 698 | 25.3% | 70.1% | -8.2 | 28.4% |
| MAT | 5 522 533 | 11.5% | 66.6% | -5.7 | 2 686 466 527 | 27.5% | 73.8% | -4.2 | 21.1% |
| ESPUMISAN BABY | |||||||||
| WoW | 20 609 | -24.1% | 42.9% | -5.3 | 12 815 038 | -24.5% | 53.3% | -5.4 | -14.7% |
| YTD | 763 904 | -2.6% | 47.6% | -3.4 | 468 811 655 | 3.6% | 58.8% | -5.9 | 4.4% |
| MAT | 1 642 971 | -6.7% | 48.4% | -1 | 988 060 873 | 2.4% | 60.3% | -1.2 | -4.8% |
| FASTUM | |||||||||
| WoW | 18 798 | -1.7% | 1.1% | 0.1 | 9 774 139 | -0.4% | 2.4% | 0.2 | -9.5% |
| YTD | 590 815 | -11.9% | 1.3% | -0.2 | 297 963 099 | -3.3% | 2.7% | -0.5 | 4.5% |
| MAT | 1 305 008 | -13.1% | 1.3% | -0.2 | 630 086 415 | -5.4% | 2.9% | -0.3 | -0.2% |
| IODOMARIN | |||||||||
| WoW | 50 206 | -4.6% | 6.4% | 0.2 | 10 019 618 | -4.0% | 9.8% | 0.4 | -7.6% |
| YTD | 1 381 566 | 8.1% | 7.1% | 0.6 | 261 865 245 | 9.5% | 9.2% | 0 | -1.2% |
| MAT | 3 250 016 | 18.6% | 8.1% | 1.8 | 605 519 662 | 18.5% | 10.9% | 2 | -7.5% |
| LIOTON | |||||||||
| WoW | 23 153 | -16.8% | 2.3% | -0.3 | 24 942 984 | -14.7% | 4.4% | -0.4 | -7.2% |
| YTD | 720 755 | -6.8% | 2.8% | -0.2 | 726 080 508 | 17.9% | 5.0% | -0.2 | -0.5% |
| MAT | 1 639 398 | -7.1% | 3.1% | -0.1 | 1 513 080 638 | 11.8% | 5.5% | -0.1 | -3.6% |
| MEZYM | |||||||||
| WoW | 195 418 | -43.9% | 19.6% | -8.5 | 30 359 458 | -42.0% | 13.6% | -6 | -19.5% |
| YTD | 10 709 974 | 29.3% | 29.7% | 3.8 | 1 638 520 107 | 39.8% | 21.3% | 1.8 | 12.7% |
| MAT | 23 184 450 | 26.5% | 30.7% | 4 | 3 375 507 575 | 32.0% | 22.4% | 1.9 | 9.9% |
| MIG 400 | |||||||||
| WoW | 123 983 | -27.3% | 3.2% | -0.8 | 14 868 011 | -26.5% | 2.3% | -0.6 | -9.2% |
| YTD | 4 447 123 | 17.0% | 3.5% | 0.1 | 521 417 589 | 19.4% | 2.7% | -0.1 | 15.0% |
| MAT | 10 537 377 | 20.0% | 3.8% | 0.4 | 1 201 441 525 | 22.0% | 3.0% | 0.2 | 6.6% |
| PROSTAMOL | |||||||||
| WoW | 22 350 | -16.5% | 18.9% | -0.3 | 31 072 061 | -16.8% | 19.7% | -0.1 | -15.2% |
| YTD | 911 898 | -6.6% | 22.1% | -3.4 | 1 282 938 510 | 5.6% | 23.2% | -4.5 | 7.8% |
| MAT | 2 075 528 | -2.2% | 24.3% | -1.7 | 2 768 506 402 | 6.3% | 25.5% | -2.6 | 4.4% |
| RESPERO MYRTOL | |||||||||
| WoW | 13 334 | -11.8% | 8.0% | 0.3 | 6 351 545 | -11.2% | 7.8% | 0.3 | -15.1% |
| YTD | 691 825 | 229.5% | 9.2% | 6.1 | 321 953 613 | 217.4% | 8.9% | 5.3 | 12.5% |
| MAT | 1 228 643 | 115.6% | 7.9% | 3.7 | 565 377 515 | 102.9% | 7.8% | 2.9 | 14.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 5 848 400 | 48.1% | 6.0% | 1.2 | 1 156 879 606 | 76.6% | 5.7% | 1.5 | 19.1% |
| DEXALGIN | 1 008 281 | 34.9% | 0.8% | 0.1 | 416 384 046 | 47.1% | 2.1% | 0.3 | 15.0% |
| ESPUMISAN (ADULTS) | 2 575 601 | 10.3% | 63.1% | -10.3 | 1 297 406 698 | 25.3% | 70.1% | -8.2 | 28.4% |
| ESPUMISAN BABY | 763 904 | -2.6% | 47.6% | -3.4 | 468 811 655 | 3.6% | 58.8% | -5.9 | 4.4% |
| FASTUM | 590 815 | -11.9% | 1.3% | -0.2 | 297 963 099 | -3.3% | 2.7% | -0.5 | 4.5% |
| IODOMARIN | 1 381 566 | 8.1% | 7.1% | 0.6 | 261 865 245 | 9.5% | 9.2% | 0 | -1.2% |
| LIOTON | 720 755 | -6.8% | 2.8% | -0.2 | 726 080 508 | 17.9% | 5.0% | -0.2 | -0.5% |
| MEZYM | 10 709 974 | 29.3% | 29.7% | 3.8 | 1 638 520 107 | 39.8% | 21.3% | 1.8 | 12.7% |
| MIG 400 | 4 447 123 | 17.0% | 3.5% | 0.1 | 521 417 589 | 19.4% | 2.7% | -0.1 | 15.0% |
| PROSTAMOL | 911 898 | -6.6% | 22.1% | -3.4 | 1 282 938 510 | 5.6% | 23.2% | -4.5 | 7.8% |
| RESPERO MYRTOL | 691 825 | 229.5% | 9.2% | 6.1 | 321 953 613 | 217.4% | 8.9% | 5.3 | 12.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 15 168 378 | 64.3% | 6.8% | 2 | 2 792 538 406 | 94.7% | 6.3% | 2.1 | 15.7% |
| DEXALGIN | 2 099 737 | 8.6% | 0.8% | 0 | 834 312 630 | 16.6% | 2.1% | 0.1 | 6.6% |
| ESPUMISAN (ADULTS) | 5 522 533 | 11.5% | 66.6% | -5.7 | 2 686 466 527 | 27.5% | 73.8% | -4.2 | 21.1% |
| ESPUMISAN BABY | 1 642 971 | -6.7% | 48.4% | -1 | 988 060 873 | 2.4% | 60.3% | -1.2 | -4.8% |
| FASTUM | 1 305 008 | -13.1% | 1.3% | -0.2 | 630 086 415 | -5.4% | 2.9% | -0.3 | -0.2% |
| IODOMARIN | 3 250 016 | 18.6% | 8.1% | 1.8 | 605 519 662 | 18.5% | 10.9% | 2 | -7.5% |
| LIOTON | 1 639 398 | -7.1% | 3.1% | -0.1 | 1 513 080 638 | 11.8% | 5.5% | -0.1 | -3.6% |
| MEZYM | 23 184 450 | 26.5% | 30.7% | 4 | 3 375 507 575 | 32.0% | 22.4% | 1.9 | 9.9% |
| MIG 400 | 10 537 377 | 20.0% | 3.8% | 0.4 | 1 201 441 525 | 22.0% | 3.0% | 0.2 | 6.6% |
| PROSTAMOL | 2 075 528 | -2.2% | 24.3% | -1.7 | 2 768 506 402 | 6.3% | 25.5% | -2.6 | 4.4% |
| RESPERO MYRTOL | 1 228 643 | 115.6% | 7.9% | 3.7 | 565 377 515 | 102.9% | 7.8% | 2.9 | 14.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 67 482 | -51.9% | 3.3% | -2.5 | 13 815 442 | -50.3% | 3.1% | -2.2 | -15.7% |
| DEXALGIN | 18 656 | -46.0% | 0.5% | -0.3 | 8 371 881 | -42.9% | 1.3% | -0.8 | -9.2% |
| ESPUMISAN (ADULTS) | 54 025 | -41.3% | 52.9% | -10.7 | 28 300 356 | -39.5% | 61.5% | -8.7 | -29.5% |
| ESPUMISAN BABY | 20 609 | -24.1% | 42.9% | -5.3 | 12 815 038 | -24.5% | 53.3% | -5.4 | -14.7% |
| FASTUM | 18 798 | -1.7% | 1.1% | 0.1 | 9 774 139 | -0.4% | 2.4% | 0.2 | -9.5% |
| IODOMARIN | 50 206 | -4.6% | 6.4% | 0.2 | 10 019 618 | -4.0% | 9.8% | 0.4 | -7.6% |
| LIOTON | 23 153 | -16.8% | 2.3% | -0.3 | 24 942 984 | -14.7% | 4.4% | -0.4 | -7.2% |
| MEZYM | 195 418 | -43.9% | 19.6% | -8.5 | 30 359 458 | -42.0% | 13.6% | -6 | -19.5% |
| MIG 400 | 123 983 | -27.3% | 3.2% | -0.8 | 14 868 011 | -26.5% | 2.3% | -0.6 | -9.2% |
| PROSTAMOL | 22 350 | -16.5% | 18.9% | -0.3 | 31 072 061 | -16.8% | 19.7% | -0.1 | -15.2% |
| RESPERO MYRTOL | 13 334 | -11.8% | 8.0% | 0.3 | 6 351 545 | -11.2% | 7.8% | 0.3 | -15.1% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 TABS TUNIC 25 MG #10"
## [1] "MIG 400"
## [1] "MIG 400 TABS TUNIC 400 MG #10"
## [1] "MIG 400 TABS TUNIC 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs